KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Gains from Investment Securities (2016 - 2025)

Emergent BioSolutions' Gains from Investment Securities history spans 16 years, with the latest figure at $1.4 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 36.36% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $12.7 million, up 370.37%, while the annual FY2025 figure was -$400000.0, 136.36% down from the prior year.
  • Gains from Investment Securities reached $1.4 million in Q4 2025 per EBS's latest filing, down from $11.3 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $12.2 million in Q1 2021 to a low of -$6.1 million in Q4 2021.
  • Average Gains from Investment Securities over 5 years is $1.3 million, with a median of $600000.0 recorded in 2021.
  • Peak YoY movement for Gains from Investment Securities: plummeted 2600.0% in 2023, then skyrocketed 2725.0% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at -$6.1 million in 2021, then surged by 103.28% to $200000.0 in 2022, then tumbled by 2600.0% to -$5.0 million in 2023, then surged by 144.0% to $2.2 million in 2024, then tumbled by 36.36% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for EBS's Gains from Investment Securities are $1.4 million (Q4 2025), $11.3 million (Q1 2025), and $2.2 million (Q4 2024).